Inflammatory Bowel Disease: An interview with Dr. John Marshall
Main Article Content
Abstract
Dr. John Marshall is a Professor of Medicine, a Full Member of the Farncombe Family Digestive Health Research Institute, and Head of Clinical Research for the Division of Gastroenterology at McMaster University. He is also Chief of Service for Gastroenterology at Hamilton Health Sciences. Dr. Marshall’s clinical and research interests include Inflammatory Bowel Disease (IBD), a group of chronic disorders that cause prolonged inflammation of the gastrointestinal tract. We were able to speak with Dr. Marshall about his clinical and research experiences with IBD and his advice for interested trainees who want to pursue a career in academic medicine.
Article Details
Section
Interview
- Authors publishing in the UOJM retain copyright of their articles, including all the drafts and the final published version in the journal.
- While UOJM does not retain any rights to the articles submitted, by agreeing to publish in UOJM, authors are granting the journal right of first publication and distribution rights of their articles.
- Authors are free to submit their works to other publications, including journals, institutional repositories or books, with an acknowledgment of its initial publication in UOJM.
- Copies of UOJM are distributed both in print and online, and all materials will be publicly available online. The journal holds no legal responsibility as to how these materials will be used by the public.
- Please ensure that all authors, co-authors and investigators have read and agree to these terms.
- Works are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Marshall JK, Cawdron R, Zealley I, Riddell RH, Somers S, Irvine EJ. Prospective comparison of small bowel meal with pneumocolon versus ileoscopy for diagnosis of ileal Crohn’s disease. Am J Gastroenterol 2004;99:1321-9.
Marshall JK, Blackhouse G, Goeree R, Brazier N, Irvine E, Faulkner L, Dipchand C, O’Brien B. Infliximab for the Treatment of Crohn’s Disease: A systematic Review and Cost-Utility Analysis. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 2002. Technology Report no 24.
Marshall JK, Blackhouse G, Goeree R, Brazier N, Irvine E, Faulkner L, Dipchand C, O’Brien B. Infliximab for the Treatment of Crohn’s Disease: A systematic Review and Cost-Utility Analysis. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 2002. Technology Report no 24.